Doctor profile · Federal record
Dr. Laura Fox, PA-C
Physician Assistant · Grand Island, NE
- NPI 1023078425
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 29 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
418 N Webb RD
Grand Island, NE 688034045
(308) 384-9300
fax (308) 384-4542 - Mailing address
-
Po Box 5436
Grand Island, NE 688025436
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- Medicaid
- NE #10025016800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023078425. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,944
Distinct HCPCS
10
Medicare allowed
$195,844
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,311 | 337 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,003 | 729 | $72 | |
17000 |
Destruction of precancer skin growth, 1 growth | 615 | 448 | $45 | |
11102 |
Biopsy of related skin growth, first growth | 270 | 239 | $75 | |
17110 |
Destruction of skin growth, 1-14 growths | 209 | 184 | $90 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 141 | 141 | $88 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 106 | 81 | $134 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 84 | 79 | $45 | |
11103 |
Biopsy of related skin growth, each additional growth | 74 | 47 | $40 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 71 | 66 | $101 |
In context: peer comparison
Among 8 peers in Grand Island Physician Assistant, average services per provider: 152. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$1,565
Transactions
88
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 25 | $400.51 | |
| Lilly USA, LLC | 14 | $200.37 | |
| Sun Pharmaceutical Industries INC. | 8 | $187.65 | |
| Janssen Biotech, INC. | 6 | $164.73 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $148.74 | |
| Incyte Corporation | 6 | $96.84 | |
| Ucb, INC. | 5 | $84.00 | |
| Novartis Pharmaceuticals Corporation | 4 | $60.86 | |
| Boston Scientific Corporation | 1 | $50.46 | |
| Sandoz INC. | 2 | $42.33 | |
| Pfizer INC. | 2 | $29.48 | |
| Leo Pharma INC. | 1 | $19.02 | |
| Amgen INC. | 1 | $17.55 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $17.13 | |
| Genzyme Corporation | 1 | $16.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
362
Patients
201
Total drug cost
$314,036
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 132 | 63 | $3,609 |
| Triamcinolone Acetonide | Generic | 36 | 31 | $382 |
| Mupirocin | Generic | 35 | 30 | $276 |
| Mometasone Furoate | Generic | 29 | 21 | $876 |
| Clobetasol Propionate | Generic | 27 | 18 | $1,997 |
| Humira(Cf) Pen (Adalimumab) | Brand | 23 | 0 | $247,799 |
| Doxycycline Hyclate | Generic | 21 | 21 | $432 |
| Fluorouracil | Generic | 20 | 17 | $2,431 |
| Dupixent Pen (Dupilumab) | Brand | 14 | 0 | $54,193 |
| Tacrolimus | Generic | 13 | 0 | $1,406 |
Hospital affiliations
Frequently asked questions
What is Dr. Laura Fox's medical specialty?
Dr. Laura Fox practices Physician Assistant in Grand Island, NE.
Where does Dr. Laura Fox practice?
Dr. Laura Fox practices at 418 N Webb RD, Grand Island, NE 688034045. Office phone: 3083849300.
What is Dr. Laura Fox's NPI?
Dr. Laura Fox's National Provider Identifier (NPI) is 1023078425, issued by NPPES.
Does Dr. Laura Fox accept Medicare assignment?
Yes. Dr. Laura Fox accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Laura Fox commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.